Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Physiol
2003 Feb 15;547Pt 1:147-57. doi: 10.1113/jphysiol.2002.035436.
Show Gene links
Show Anatomy links
Amyloid beta(1-42) peptide alters the gating of human and mouse alpha-bungarotoxin-sensitive nicotinic receptors.
Grassi F
,
Palma E
,
Tonini R
,
Amici M
,
Ballivet M
,
Eusebi F
.
???displayArticle.abstract???
The beta-amyloid(1-42) peptide (Abeta(1-42)), a major constituent of the Alzheimer's disease amyloid plaque, specifically binds to the neuronal alpha-bungarotoxin (alpha-BuTx)-sensitive alpha7 nicotinic acetylcholine receptor (alpha7 nAChR). Accordingly, Abeta1-42 interferes with the function of alpha7 nAChRs in chick and rodent neurons. To gain insights into the human disease, we studied the action of Abeta(1-42) on human alpha7 nAChRs expressed in Xenopus oocytes. In voltage-clamped oocytes expressing the wild-type receptor, Abeta(1-42) blocked ACh-evoked currents. The block was non-competitive, required over 100 s to develop and was partially reversible. In oocytes expressing the mutant L248T receptor, Abeta(1-42) activated methyllycaconitine-sensitive currents in a dose-dependent manner. Peptide-evoked unitary events, recorded in outside-out patches, showed single-channel conductances and open duration comparable to ACh-evoked events. Abeta(1-42) had no effect on the currents evoked by glutamate, GABA or glycine in oocytes expressing human or mouse receptors for these transmitters. Muscle nAChRs are also alpha-BuTx-sensitive and we therefore investigated whether they respond to Abeta(1-42). In human kidney BOSC 23 cells expressing the fetal or adult mouse muscle nAChRs, Abeta(1-42) blocked ACh-evoked whole-cell currents, accelerating their decay. Outside-out single-channel recordings showed that the block was due to a reduced channel open probability and enhanced block upon ACh application. We also report that the inverse peptide Abeta(42-1), but not Abeta(40-1), partially mimicked the effects of the physiological Abeta(1-42) peptide. Possible implications for degenerative neuronal and muscular diseases are discussed.
Askanas,
Does overexpression of betaAPP in aging muscle have a pathogenic role and a relevance to Alzheimer's disease? Clues from inclusion body myositis, cultured human muscle, and transgenic mice.
1998, Pubmed
Askanas,
Does overexpression of betaAPP in aging muscle have a pathogenic role and a relevance to Alzheimer's disease? Clues from inclusion body myositis, cultured human muscle, and transgenic mice.
1998,
Pubmed
Atkins,
The MAPK cascade is required for mammalian associative learning.
1998,
Pubmed
Coles,
Solution structure of amyloid beta-peptide(1-40) in a water-micelle environment. Is the membrane-spanning domain where we think it is?
1998,
Pubmed
Dineley,
Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal alpha7 nicotinic acetylcholine receptors: In vitro and in vivo mechanisms related to Alzheimer's disease.
2001,
Pubmed
Dineley,
beta -Amyloid peptide activates alpha 7 nicotinic acetylcholine receptors expressed in Xenopus oocytes.
2002,
Pubmed
,
Xenbase
Fucile,
Human neuronal threonine-for-leucine-248 alpha 7 mutant nicotinic acetylcholine receptors are highly Ca2+ permeable.
2000,
Pubmed
,
Xenbase
Fucile,
Identification of a determinant of acetylcholine receptor gating kinetics in the extracellular portion of the gamma subunit.
1996,
Pubmed
Fucile,
Serotonin antagonizes the human neuronal alpha7 nicotinic acetylcholine receptor and becomes an agonist after L248T alpha7 mutation.
2002,
Pubmed
,
Xenbase
Giordano,
Similarities between beta amyloid peptides 1-40 and 40-1: effects on aggregation, toxicity in vitro, and injection in young and aged rats.
1994,
Pubmed
Grassi,
5-hydroxytryptamine blocks the fetal more potently than the adult mouse muscle acetylcholine receptor.
1999,
Pubmed
Guan,
Decreased protein levels of nicotinic receptor subunits in the hippocampus and temporal cortex of patients with Alzheimer's disease.
2000,
Pubmed
Kullberg,
Multiple conductance classes of mouse nicotinic acetylcholine receptors expressed in Xenopus oocytes.
1990,
Pubmed
,
Xenbase
Kuo,
Elevated abeta42 in skeletal muscle of Alzheimer disease patients suggests peripheral alterations of AbetaPP metabolism.
2000,
Pubmed
Kuo,
Amyloid-beta peptides interact with plasma proteins and erythrocytes: implications for their quantitation in plasma.
2000,
Pubmed
Liou,
Association analysis of the partially duplicated alpha7 nicotinic acetylcholine receptor genetic variant and Alzheimer's disease.
2001,
Pubmed
Liu,
beta -Amyloid peptide blocks the response of alpha 7-containing nicotinic receptors on hippocampal neurons.
2001,
Pubmed
Maggi,
Selective effects of a 4-oxystilbene derivative on wild and mutant neuronal chick alpha7 nicotinic receptor.
1999,
Pubmed
,
Xenbase
Mehta,
Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease.
2000,
Pubmed
Methfessel,
Patch clamp measurements on Xenopus laevis oocytes: currents through endogenous channels and implanted acetylcholine receptor and sodium channels.
1986,
Pubmed
,
Xenbase
Miledi,
Expression of functional neurotransmitter receptors in Xenopus oocytes after injection of human brain membranes.
2002,
Pubmed
,
Xenbase
Moechars,
Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain.
1999,
Pubmed
Nagele,
Intracellular accumulation of beta-amyloid(1-42) in neurons is facilitated by the alpha 7 nicotinic acetylcholine receptor in Alzheimer's disease.
2002,
Pubmed
Neve,
Alzheimer's disease: a re-examination of the amyloid hypothesis.
1998,
Pubmed
Nordberg,
Nicotinic receptor abnormalities of Alzheimer's disease: therapeutic implications.
2001,
Pubmed
Palma,
Neuronal nicotinic threonine-for-leucine 247 alpha7 mutant receptors show different gating kinetics when activated by acetylcholine or by the noncompetitive agonist 5-hydroxytryptamine.
1997,
Pubmed
,
Xenbase
Palma,
Effects of Zn2+ on wild and mutant neuronal alpha7 nicotinic receptors.
1998,
Pubmed
,
Xenbase
Palma,
Strychnine activates neuronal alpha7 nicotinic receptors after mutations in the leucine ring and transmitter binding site domains.
1999,
Pubmed
,
Xenbase
Palma,
Threonine-for-leucine mutation within domain M2 of the neuronal alpha(7) nicotinic receptor converts 5-hydroxytryptamine from antagonist to agonist.
1996,
Pubmed
,
Xenbase
Pettit,
beta-Amyloid(1-42) peptide directly modulates nicotinic receptors in the rat hippocampal slice.
2001,
Pubmed
Revah,
Mutations in the channel domain alter desensitization of a neuronal nicotinic receptor.
1991,
Pubmed
,
Xenbase
Selkoe,
Alzheimer's disease: genes, proteins, and therapy.
2001,
Pubmed
Selkoe,
Normal and abnormal biology of the beta-amyloid precursor protein.
1994,
Pubmed
Simmons,
Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro.
1994,
Pubmed
Smith,
Imaging the progression of Alzheimer pathology through the brain.
2002,
Pubmed
Sugarman,
Inclusion body myositis-like phenotype induced by transgenic overexpression of beta APP in skeletal muscle.
2002,
Pubmed
Tozaki,
The inhibitory and facilitatory actions of amyloid-beta peptides on nicotinic ACh receptors and AMPA receptors.
2002,
Pubmed
,
Xenbase
Wang,
Amyloid peptide Abeta(1-42) binds selectively and with picomolar affinity to alpha7 nicotinic acetylcholine receptors.
2000,
Pubmed
Wang,
Cerebellar diffuse amyloid plaques are derived from dendritic Abeta42 accumulations in Purkinje cells.
2002,
Pubmed
Wang,
beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology.
2000,
Pubmed
